Robert Armstrong There has been a wild and hectic series of M&A deals in the pharmaceuticals industry. We are now headed for ...
Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...
Right now, that's none other than Eli Lilly (NYSE: LLY). However, others are looking to challenge its dominance. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback